---
title: "Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48â€‰weeks of treatment."
date: 2022-12-13
enddate:
---

Published in: *Muscle & nerve*

DOI: [10.1002/mus.27768](https://doi.org/10.1002/mus.27768)

<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/0/0e/Closed_Access_logo_transparent.svg/1200px-Closed_Access_logo_transparent.svg.png" alt="drawing" width="25" align="left"/> &nbsp;&nbsp;&nbsp;This publication is not available in Open Access.


